BiomarkersIn silico

Anti-aging clock results often fail across multiple models

When researchers applied extra biological age clocks to previously tested anti-aging treatments, no additional clock showed a statistically meaningful effect.

Aging Cell

In a computational study, researchers analysed data from published anti-aging intervention studies, datasets of age-accelerating events, and computer simulations. Epigenetic clocks estimate biological age by tracking chemical tags on DNA. The researchers found that when extending published single-clock intervention studies to include additional clock models, no additional clocks reached statistical significance. From the age-accelerating datasets, they proposed three criteria that increase confidence in a result: reliable principal-component-based (PC-based) clocks respond, mortality-trained or pace-of-aging clocks respond, and multiple clocks respond in the same direction. Simulations showed that reliable clocks are more sensitive to true effects. In longitudinal control datasets, changes in reliable clocks correlated with each other. The researchers also showed examples of interventions that satisfied these criteria.

Why it matters

Epigenetic clocks are increasingly used to test whether candidate therapies slow biological aging. Clearer standards for interpreting these tests may help researchers distinguish true changes from statistical false alarms.

Caveats

The proposed rules are a framework based on simulations and existing datasets rather than a formally validated standard. The findings also suggest that several previously published single-clock study results may warrant re-examination.

The paper

When to Trust Epigenetic Clocks: Avoiding False Positives in Aging Interventions

Daniel S Borrus, Raghav Sehgal, Jenel Fraij Armstrong,
Show 2 more authorsJessica Kasamoto, John Gonzalez,
Albert Higgins-Chen

Yale University School of Medicine

Aging Cell · 1 Oct 2026

doi.org/10.1111/acel.70756PubMed 42850743